Synergistic Anti-inflammatory Effects of Nobiletin and Sulforaphane in Lipopolysaccharide-Stimulated RAW 264.7 Cells

Inflammation plays important roles in the initiation and progress of many diseases including cancers in multiple organ sites. Herein, we investigated the anti-inflammatory effects of two dietary compounds, nobiletin (NBN) and sulforaphane (SFN), in combination. Noncytotoxic concentrations of NBN, SF...

Full description

Saved in:
Bibliographic Details
Published inJournal of agricultural and food chemistry Vol. 60; no. 9; pp. 2157 - 2164
Main Authors Guo, Shanshan, Qiu, Peiju, Xu, Guang, Wu, Xian, Dong, Ping, Yang, Guanpin, Zheng, Jinkai, McClements, David Julian, Xiao, Hang
Format Journal Article
LanguageEnglish
Published Washington, DC American Chemical Society 07.03.2012
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Inflammation plays important roles in the initiation and progress of many diseases including cancers in multiple organ sites. Herein, we investigated the anti-inflammatory effects of two dietary compounds, nobiletin (NBN) and sulforaphane (SFN), in combination. Noncytotoxic concentrations of NBN, SFN, and their combinations were studied in lipopolysaccharide (LPS)-stimulated RAW 264.7 macrophage cells. The results showed that combined NBN and SFN treatments produced much stronger inhibitory effects on the production of nitric oxide (NO) than NBN or SFN alone at higher concentrations. These enhanced inhibitory effects were synergistic based on the isobologram analysis. Western blot analysis showed that combined NBN and SFN treatments synergistically decreased iNOS and COX-2 protein expression levels and induced heme oxygenase-1 (HO-1) protein expression. Real-time polymerase chain reaction analysis indicated that low doses of NBN and SFN in combination significantly suppressed LPS-induced upregulation of IL-1 mRNA levels and synergistically increased HO-1 mRNA levels. Overall, our results demonstrated that NBN and SFN in combination produced synergistic effects in inhibiting LPS-induced inflammation in RAW 264.7 cells.
Bibliography:http://dx.doi.org/10.1021/jf300129t
The authors have declared no conflict of interest.
ISSN:0021-8561
1520-5118
DOI:10.1021/jf300129t